Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Dunne

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
European Journal of Endocrinology|March 7, 2014
Insulinoma in childhood: clinical, radiological, molecular and histological aspects of nine patientsRaja Padidela, Miriam Fiest, Ved Arya, et al.
Frontiers in Endocrinology|June 5, 2013
Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital HyperinsulinismHima Bindu Avatapalle, Indraneel Banerjee, Sajni Shah, et al.
American Journal of Clinical Pathology|June 24, 2016
Enhanced Islet Cell Nucleomegaly Defines Diffuse Congenital Hyperinsulinism in Infancy but Not Other Forms of the DiseaseBing Han, Melanie Newbould, Gauri Batra, et al.
Orphanet Journal of Rare Diseases|December 3, 2016
Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over timeMaria Salomon-Estebanez, Sarah E Flanagan, Sian Ellard, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|April 11, 2022
Pancreatic ductal adenocarcinoma cells employ integrin α6β4 to form hemidesmosomes and regulate cell proliferationJonathan D Humphries, Junzhe Zha, Jessica Burns, et al.
Journal of the Endocrine Society|May 20, 2022
Variation in Glycemic Outcomes in Focal Forms of Congenital Hyperinsulinism-The UK PerspectiveAntonia Dastamani, Daphne Yau, Clare Gilbert, et al.
Frontiers in Endocrinology|November 3, 2018
Clinical Diversity in Focal Congenital Hyperinsulinism in Infancy Correlates With Histological Heterogeneity of Islet Cell LesionsRoss J Craigie, Maria Salomon-Estebanez, Daphne Yau, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2016
mTOR Inhibitors for the Treatment of Severe Congenital Hyperinsulinism: Perspectives on Limited Therapeutic SuccessMarie Szymanowski, Maria Salomon Estebanez, Raja Padidela, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Acute insulin responses to calcium and tolbutamide do not differentiate focal from diffuse congenital hyperinsulinismIrina Giurgea, Kathleen Laborde, Guy Touati, et al.
Diabetes|May 2, 2015
Altered Phenotype of β-Cells and Other Pancreatic Cell Lineages in Patients With Diffuse Congenital Hyperinsulinism in Infancy Caused by Mutations in the ATP-Sensitive K-ChannelRachel J Salisbury, Bing Han, Rachel E Jennings, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
European Journal of Endocrinology|March 7, 2014
Insulinoma in childhood: clinical, radiological, molecular and histological aspects of nine patientsRaja Padidela, Miriam Fiest, Ved Arya, et al.
Frontiers in Endocrinology|June 5, 2013
Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital HyperinsulinismHima Bindu Avatapalle, Indraneel Banerjee, Sajni Shah, et al.
American Journal of Clinical Pathology|June 24, 2016
Enhanced Islet Cell Nucleomegaly Defines Diffuse Congenital Hyperinsulinism in Infancy but Not Other Forms of the DiseaseBing Han, Melanie Newbould, Gauri Batra, et al.
Orphanet Journal of Rare Diseases|December 3, 2016
Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over timeMaria Salomon-Estebanez, Sarah E Flanagan, Sian Ellard, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|April 11, 2022
Pancreatic ductal adenocarcinoma cells employ integrin α6β4 to form hemidesmosomes and regulate cell proliferationJonathan D Humphries, Junzhe Zha, Jessica Burns, et al.
Journal of the Endocrine Society|May 20, 2022
Variation in Glycemic Outcomes in Focal Forms of Congenital Hyperinsulinism-The UK PerspectiveAntonia Dastamani, Daphne Yau, Clare Gilbert, et al.
Frontiers in Endocrinology|November 3, 2018
Clinical Diversity in Focal Congenital Hyperinsulinism in Infancy Correlates With Histological Heterogeneity of Islet Cell LesionsRoss J Craigie, Maria Salomon-Estebanez, Daphne Yau, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2016
mTOR Inhibitors for the Treatment of Severe Congenital Hyperinsulinism: Perspectives on Limited Therapeutic SuccessMarie Szymanowski, Maria Salomon Estebanez, Raja Padidela, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Acute insulin responses to calcium and tolbutamide do not differentiate focal from diffuse congenital hyperinsulinismIrina Giurgea, Kathleen Laborde, Guy Touati, et al.
Diabetes|May 2, 2015
Altered Phenotype of β-Cells and Other Pancreatic Cell Lineages in Patients With Diffuse Congenital Hyperinsulinism in Infancy Caused by Mutations in the ATP-Sensitive K-ChannelRachel J Salisbury, Bing Han, Rachel E Jennings, et al.
Pageof 5